Histogen Inc. (HSTO)
OTHER OTC:HSTO
US Market
Holding HSTO?
Track your performance easily

Histogen (HSTO) Income Statement

650 Followers

Histogen Income Statement

Last quarter (Q3 2023), Histogen's total revenue was $5.00K, a decrease of 0.00% from the same quarter last year. In Q3, Histogen's net income was $-3.85M. See Histogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 19.00K$ 3.77M$ 1.03M$ 2.06M$ 11.45M
Cost of Revenue
$ 61.00K$ 61.00K$ 220.00K$ 968.00K$ 2.21M
Gross Profit
$ 19.00K$ 3.77M$ 699.00K$ 1.09M$ 9.24M
Operating Expense
$ 12.07M$ 14.41M$ 16.49M$ 20.92M$ 12.56M
Operating Income
$ -12.05M$ -10.64M$ -15.46M$ -18.86M$ -3.32M
Net Non Operating Interest Income Expense
$ -1.00K$ -1.00K$ -3.00K$ -3.00K$ 42.00K
Other Income Expense
$ 328.00K$ 1.00K$ -448.00K$ -41.00K$ -276.00K
Pretax Income
$ -12.38M$ -10.64M$ -15.01M$ -4.53M$ -3.00M
Tax Provision
$ -5.00K$ -5.00K$ -908.00K$ -34.00K$ -299.00K
Earnings From Equity Interest Net Of Tax
$ 1.00K----
Net Income Common Stockholders
$ -12.38M$ -11.11M$ -14.95M$ -18.77M$ -2.97M
Basic EPS
$ -2.83$ -3.46$ -7.80$ -41.60-
Diluted EPS
$ -2.83$ -3.46$ -7.80$ -41.60$ -68.00
Basic Average Shares
$ 17.11M$ 3.21M$ 1.92M$ 450.92K$ 165.84K
Diluted Average Shares
$ 17.11M$ 3.21M$ 1.92M$ 450.92K$ 165.84K
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 12.13M$ 14.41M$ 16.71M$ 21.60M$ 14.77M
Net Income From Continuing And Discontinued Operation
$ -12.38M$ -10.62M$ -14.95M$ -18.77M$ -2.97M
Normalized Income
$ -10.09M$ -10.65M$ -15.92M--
Interest Expense
-----
EBIT
$ -12.38M$ -10.64M$ -15.00M$ -18.75M$ -3.01M
EBITDA
$ -12.27M$ -10.50M$ -14.90M$ -18.66M$ -2.86M
Currency in USD

Histogen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis